Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Cartherics CEO and IVF Pioneer Alan Trounson joins ABC RN’s Science Friction

By Karen Loudon / October 25, 2019
A mystery and a minefield: in the 1980s, two Californian millionaires land in Melbourne hoping to have a child using...
Read More

Cartherics Board Member Bryan Williams wins 2019 ICIS Distinguished Service Award

By Karen Loudon / October 17, 2019
Bryan R. G. Williams, PhD, Hon. FRSNZ, FAA is honored with the 2019 ICIS Distinguished Service award in recognition of...
Read More

Cartherics CEO Alan Trounson discusses how Precision Medicine is changing the DNA of health care

By Karen Loudon / October 17, 2019
Precision Medicine - Changing the DNA of Health Care How precision medicine is changing the shape of health - by Alan...
Read More